75 Participants Needed

Brain Stimulation + Psychotherapy for Alcoholism

(tACS-MI Trial)

JM
Overseen ByJon M Houck, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Phase 2
Sponsor: The Mind Research Network
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether brain stimulation, specifically high-density transcranial alternating current stimulation, can enhance the effects of motivational interviewing, a type of counseling, to reduce risky drinking habits. Participants will be divided into three groups: one receiving active brain stimulation, one receiving sham stimulation, and a control group with no initial stimulation. The study will track changes in drinking habits, brain activity, and emotions. Ideal participants are right-handed individuals who recognize a drinking problem and are not currently in treatment.

As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to innovative approaches in reducing risky drinking habits.

Do I have to stop taking my current medications to join the trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are currently receiving treatment for alcohol use disorder, you are not eligible to participate.

Do I need to stop taking my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that both treatments in this study, transcranial alternating current stimulation (tACS) and motivational interviewing (MI), are generally safe. Previous studies found that tACS is usually well-tolerated, with no serious side effects reported. Rarely, some individuals might experience minor skin issues. MI, a counseling method that helps change behavior, is widely used and considered safe. Overall, existing research indicates that both treatments are safe options.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about using brain stimulation combined with psychotherapy for treating alcoholism. Unlike standard treatments, which typically involve medication or traditional therapy, this approach uses transcranial alternating current stimulation (tACS) to enhance the effects of motivational interviewing. This method aims to directly influence brain activity related to addiction and motivation, potentially offering a more effective and targeted treatment. By integrating active stimulation with psychotherapy, this innovative approach could lead to faster and more sustained recovery outcomes for individuals struggling with alcohol dependence.

What evidence suggests that this trial's treatments could be effective for alcoholism?

Research has shown that transcranial alternating current stimulation (tACS) could be a promising treatment for alcohol use disorder. This method involves non-invasive brain stimulation, meaning it doesn't require surgery or entering the body. Studies suggest that tACS can help reduce cravings and lower the risk of early relapse for people recovering from alcohol use disorder. One study found that tACS is safe and might also help those dealing with both alcohol and gambling issues.

Motivational interviewing (MI) is another approach proven effective in reducing alcohol use. Research indicates that MI can significantly decrease heavy drinking and keep people engaged in their treatment. In this trial, participants will receive either MI with active tACS, MI with sham stimulation, or MI-only. Overall, both tACS and MI have strong evidence supporting their potential to help with alcohol use disorder.26789

Are You a Good Fit for This Trial?

This trial is for right-handed individuals aged 21-60 who recognize they have a drinking problem, as indicated by their AUDIT score. They must not be currently in treatment for alcohol use disorder or have been treated in the past year, and should not have severe alcohol withdrawal history or other substance use disorders (except marijuana or nicotine).

Inclusion Criteria

You are right-handed.
AUDIT score indicating risky drinking
You consider yourself to have a drinking problem.
See 1 more

Exclusion Criteria

I cannot use American Sign Language for psychotherapy due to my hearing impairment.
You cannot have an MRI or transcranial alternating current stimulation (tACS) if you are pregnant.
I am unable to understand and give consent for treatment.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive motivational interviewing with either active tACS, sham stimulation, or no stimulation

1 session
1 visit (in-person)

Follow-up

Participants report their alcohol use in the prior 30 days via an online assessment battery

4 weeks
1 visit (virtual)

Imaging

Participants undergo MEG and MRI scans to measure the effects of brain stimulation

1 session
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • High-density transcranial alternating current stimulation
  • Motivational interviewing
Trial Overview The study tests if brain stimulation (tACS) can improve motivational interviewing therapy's effectiveness for people with risky drinking habits. Participants will either receive active stimulation during therapy, sham (fake) stimulation, or be placed in a delayed-treatment group without any brain stimulation.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: MI with tACSExperimental Treatment2 Interventions
Group II: MI-onlyActive Control1 Intervention
Group III: MI with shamPlacebo Group2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Mind Research Network

Lead Sponsor

Trials
27
Recruited
2,300+

National Institute of General Medical Sciences (NIGMS)

Collaborator

Trials
315
Recruited
251,000+

Published Research Related to This Trial

A survey of 36 motivational interviewing (MI) trainers identified key preferences for the format, duration, and content of beginner-level MI training aimed at addiction treatment, highlighting the need for effective training methods.
The survey also revealed common challenges faced by novice trainers in delivering MI training and provided recommended strategies to overcome these barriers, which is crucial for improving the implementation of evidence-based practices in community treatment settings.
Guidance for New Motivational Interviewing Trainers When Training Addiction Professionals: Findings from a Survey of Experienced Trainers.Schumacher, JA., Coffey, SF., Walitzer, KS., et al.[2021]
Integrating Motivational Interviewing (MI) with Brief Behavioral Activation Therapy for Depression (BATD) aims to enhance patient motivation, which is crucial for adherence to treatment assignments.
This combined approach not only maintains the empirical support for BATD but also addresses the common challenge of low adherence by focusing on motivation, potentially leading to better clinical outcomes.
Integrating Motivational Interviewing and Brief Behavioral Activation Therapy: Theoretical and Practical Considerations.Balán, IC., Lejuez, CW., Hoffer, M., et al.[2022]
A brief intervention combining behavioral activation and motivational interviewing significantly reduced alcohol consumption among 9 men in Kenya, with participants drinking 50% less and having 5.1 times higher odds of not drinking post-treatment.
The intervention also led to improvements in depression symptoms and family-related outcomes, indicating its potential effectiveness in addressing both problem drinking and its impact on family dynamics.
A multiple baseline study of a brief alcohol reduction and family engagement intervention for fathers in Kenya.Giusto, A., Green, EP., Simmons, RA., et al.[2021]

Citations

Effectiveness of transcranial alternating current stimulation ...Employing tDCS to target particular brain areas has demonstrated potential in mitigating cravings (Hone-Blanchet et al., 2015).
Non-invasive Brain Stimulation for Alcohol Use DisordersCurrently available data generally supports the use of non-invasive brain stimulation as a near-term treatment for alcohol use disorder.
A randomized placebo-controlled clinical trialMultiple sessions of prefrontal tDCS reduced the rate of early relapse in detoxified patients with alcohol-use disorder.
High-intensity transcranial alternating current stimulation ...The intervention was well‐tolerated. Discussion and Conclusions HI‐tACS is a safe, efficacious potential treatment for GD‐AUD comorbidity.
Alpha-tACS effect on inhibitory control and feasibility of ...To our knowledge, this is the first study of tACS in adults with a SUD. Our findings provide preliminary evidence for recruitment, retention, and administration ...
High-intensity transcranial alternating current stimulation ...Discussion and conclusions: HI-tACS is a safe, efficacious potential treatment for GD-AUD comorbidity. Scientific significance: This first ...
Adverse events of tDCS and tACS: A review - PubMed CentralNo serious adverse effects have been reported in experiments using either tDCS or tACS. Persistent adverse effects of tDCS are mainly skin problems; for tACS, ...
Brain Stimulation + Psychotherapy for Alcoholism... safety data for brain stimulation techniques like high-density transcranial alternating current stimulation (tACS) combined with psychotherapy for alcoholism.
Effects of Transcranial Alternating Current Stimulation ( ...• Indication for alcohol use disorder: AUDIT score (Alcohol Use Disorders Identification Test; screening for unhealthy alcohol use) ≥7 for ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security